Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Tiepifengdou granules** are an oral traditional Chinese medicine herbal combination containing *Dendrobium officinale* and *Panax quinquefolius*. The product is used in traditional Chinese medicine to nourish qi and yin and support gastric fluid production. It is manufactured by Zhejiang Tianhuang Pharmaceutical and is marketed in China as an OTC Chinese patent medicine. Clinical development has included randomized placebo-controlled studies for chronic atrophic gastritis with qi-yin deficiency, including a completed Chinese phase 3 trial. Its molecular pharmacology has not been established as a defined single-target mechanism. ([pharnexcloud.com](https://www.pharnexcloud.com/data/lcsy_25208ecb79eb1f8e1444fdf915e97673.html))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tiepifengdou granules.